PHARMACOGENETICS - Precision Medicine and a Physician Portal for Support

Secure, portable patient medical data and accurate precision medicine solutions remain elusive in the marketplace.  It is believed that giving patients the ability to see and track their diagnostic test results can empower them to be better advocates for their own health. 

The PDM APP will source clinical data from a patient’s health record (EMR) and consolidate this information within a secure, distributed data environment. 

Now, with AI Charlie and our PGx Precision Medicine as an available tool, the physician will know a patient's metabolization rate for a medication and can precisely deliver the proper medication and dose to provide better patient outcomes.

A primary component to the PDM program is our commitment to change personalized health care from a "symptom plan to a predictive plan". 

Pharmacogenetic (PGx) testing is a type of genetic test that assesses a patient's risk of an adverse response or likelihood to respond to a given drug, informing drug selection and dosing.  Targeted exome PGx capture panels are gaining popularity for pharmacogenetic testing due to their time- and cost-effectiveness, and ability to simultaneously detect common and rare genetic variation. 

Data collected from a patients P450 test identifies your personal metabolism rate for many of the commonly prescribed medications issued today.  

The P450 results will not change throughout a patient’s life.

Three critical components to providing better patient outcomes within the PDM APP will include the P450 life-long metabolism information necessary to prescribe and deliver the right medicine, to the right patient and at the right dosage.  

Not only will this lower health insurance and hospital costs, medication compliance and drug adherence, it will increase patient engagement & care-coordination. 

, . . . all to improve patient outcomes.